These new models are specially trained to recognize when an LLM is potentially going off the rails. If they don’t like how an interaction is going, they have the power to stop it. Of course, every ...

Compass International Holdings has named a new president of the Compass brokerage operation. In a LinkedIn post on Monday night, Robert Reffkin, the CEO and chairman of Compass International Holdings, ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Compass Pathways on ...

Compass Pathways has reported another phase 3 win for its psilocybin therapy in treatment-resistant depression, sending the British biotech’s share price up 30% and teeing up talks about filing for ...

Phase 3 clinical trial data has been a success. COMP360 is the first traditional psychedelic to consistently deliver a highly statistically significant outcome. Results included maintaining a ...

Compass, the nation’s largest residential real-estate brokerage, has a pitch for home buyers: Sign with us, and you’ll see homes nobody else can. The company maintains a growing inventory of “Private ...

Compass Pathways (CMPS) added ~20% in the premarket on Tuesday after the U.K.-based biotech announced that its psychedelic therapy COMP360 reached the primary endpoint in a late-stage trial for ...

Assurant launched a new home warranty product for real estate transactions through a partnership with six Compass International Holdings–affiliated brands. Offered to roughly 300,000 agents, the ...

In February 2020, Compass Coffee’s founders put together a presentation for potential investors in their Washington-based company. The deck laid out the owners’ vision: Michael Haft and Harrison ...

Two highly statistically significant positive Phase 3 trials confirm highly differentiated profile for COMP360, demonstrating a level of clinical effect that has historically been extremely difficult ...

The American Depositary Shares ("ADS") of the United Kingdom-based biotech Compass Pathways plc (CMPS) are soaring today, after management announced its psychedelic drug candidate COMP006 had met the ...

The client, Kyle Blackmon, is a real estate broker with Compass. He was seeking $19.7 million in damages. According to the FINRA arbitration award, Blackmon will receive $5.375 million in compensatory ...